These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 25286052)

  • 1. Alloimmune responses and atherosclerotic disease after kidney transplantation.
    Ducloux D; Courivaud C; Bamoulid J; Bisaccia V; Roubiou C; Crepin T; Gaugler B; Laheurte C; Rebibou JM; Chalopin JM; Saas P
    Transplantation; 2015 Jan; 99(1):220-5. PubMed ID: 25286052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation.
    Kanter Berga J; Sancho Calabuig A; Gavela Martinez E; Puig Alcaraz N; Beltran Catalan S; Avila Bernabeu A; Crespo Albiach J; Montoro JA; Pallardo Mateu LM
    Transplant Proc; 2012 Nov; 44(9):2529-31. PubMed ID: 23146444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric kidney transplantation: analysis of donor age, HLA match, and posttransplant non-Hodgkin lymphoma: a collaborative transplant study report.
    Opelz G; Döhler B
    Transplantation; 2010 Aug; 90(3):292-7. PubMed ID: 20548266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terminally differentiated CD8+ Temra cells are associated with the risk for acute kidney allograft rejection.
    Betjes MG; Meijers RW; de Wit EA; Weimar W; Litjens NH
    Transplantation; 2012 Jul; 94(1):63-9. PubMed ID: 22691956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation results of completely HLA-mismatched living and completely HLA-matched deceased-donor kidneys are comparable.
    Laging M; Kal-van Gestel JA; Haasnoot GW; Claas FH; van de Wetering J; Ijzermans JN; Weimar W; Roodnat JI
    Transplantation; 2014 Feb; 97(3):330-6. PubMed ID: 24202143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-specific HLA antibodies: risk factors and outcomes after kidney transplantation.
    Kanter Berga J; Pallardo Mateu LM; Beltran Catalan S; Puig Alcaraz N; Sancho Calabuig A; Gavela Martinez E; Avila Bernabeu A; Crespo Albiach J
    Transplant Proc; 2011; 43(6):2154-6. PubMed ID: 21839219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
    Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
    Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of HLA mismatching on incidence of posttransplant non-hodgkin lymphoma after kidney transplantation.
    Opelz G; Döhler B
    Transplantation; 2010 Mar; 89(5):567-72. PubMed ID: 20110857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transplant DSA monitoring may predict antibody-mediated rejection in sensitized kidney transplant recipients.
    Mohamed MA; Muth B; Vidyasagar V; Foley D; Fernandez L; Hofmann RM; Mezrich J; Pirsch J; Odorico J; d'Alessandro T; Bellingham J; Torrealba J; Kaufman D; Djamali A
    Clin Transpl; 2011; ():389-94. PubMed ID: 22755436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of transplant outcomes after five or six human leukocyte antigen-mismatched living donor kidney transplantation.
    Lee HS; Kim MS; Kim YS; Joo DJ; Ju MK; Kim SJ; Kim SI; Huh KH; Park K
    Transplant Proc; 2012 Jan; 44(1):273-5. PubMed ID: 22310631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What kind of changes occurred in clinical characteristics of deceased kidney donor recipients after national allocation system in Turkey? A single-center retrospective analysis.
    Solak I; Sezer TO; Toz H; Tatar E; Sozbilen M; Firat O; Hoscoskun C
    Transplant Proc; 2012; 44(6):1598-600. PubMed ID: 22841223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased activation and expansion of a CD57+ subset within peripheral CD8+ T lymphocytes in Mycobacterium tuberculosis-infected patients.
    Fateminasab FD; Shahgasempour S; Mirsaeidi SM; Tabarsi P; Mansoori SD; Entezami Z
    Arch Iran Med; 2006 Jan; 9(1):53-7. PubMed ID: 16649379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart transplant graft survival is improved after a reduction in panel reactive antibody activity.
    Schaffer JM; Singh SK; Reitz BA; Oyer PE; Robbins RC; Mallidi HR
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):555-64; discussion 564-5. PubMed ID: 23246047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for surgical complications after renal transplantation and impact on patient and graft survival.
    Pillot P; Bardonnaud N; Lillaz J; Delorme G; Chabannes E; Bernardini S; Guichard G; Bittard H; Kleinclauss F
    Transplant Proc; 2012 Nov; 44(9):2803-8. PubMed ID: 23146528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney transplantation in the US: an analysis of the OPTN/UNOS registry.
    Freitas MC
    Clin Transpl; 2011; ():1-16. PubMed ID: 22755397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
    Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent of nephrectomy, weaning immunosuppression leads to late sensitization after kidney transplant failure.
    Augustine JJ; Woodside KJ; Padiyar A; Sanchez EQ; Hricik DE; Schulak JA
    Transplantation; 2012 Oct; 94(7):738-43. PubMed ID: 22955228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course of pathologic changes in kidney allografts of positive crossmatch HLA-incompatible transplant recipients.
    Bagnasco SM; Zachary AA; Racusen LC; Arend LJ; Carter-Monroe N; Alachkar N; Nazarian SM; Lonze BE; Montgomery RA; Kraus ES
    Transplantation; 2014 Feb; 97(4):440-5. PubMed ID: 24531821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus infection in renal transplant recipients: one center's experience.
    Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M
    Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.